Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2024 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

palatin tech - PTN

PTN

Close Chg Chg %
0.95 0.16 16.77%

Closed Market

1.11

+0.16 (16.77%)

Volume: 429.68K

Last Updated:

Dec 26, 2024, 3:59 PM EDT

Trade Now

Company Overview: palatin tech - PTN

PTN Key Data

Open

$0.99

 Day Range

0.96 - 1.11

52 Week Range

0.68 - 5.65

 Market Cap

$19.35M

Shares Outstanding

19.55M

 Public Float

18.79M

Beta

0.91

 Rev. Per Employee

N/A

P/E Ratio

N/A

 EPS

-$1.97

Yield

0.00%

 Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

590.79K

  

PTN Performance

1 Week
 
 14.68%
 
1 Month
 
 -2.63%
 
3 Months
 
 32.05%
 
1 Year
 
 -72.11%
 
5 Years
 
 -94.45%
 

PTN Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 1
Full Ratings ➔

About palatin tech - PTN

Palatin Technologies, Inc. is a biopharmaceutical company, which engages in the development of medicines based on molecules that modulate the activity of the melanocortin receptor system. Its primary product candidate is marketed under the Vyleesi brand, the trade name for bremelanotide, which is used for the treatment of premenopausal women with acquired, generalized, hypoactive sexual desire disorder (HSDD). The company was founded by Carl Spana and John K. A. Prendergast on November 21, 1986 and is headquartered in Cranbury, NJ.

PTN At a Glance

Palatin Technologies, Inc.
Cedar Brook Corporate Center
Cranbury, New Jersey 08512
Phone 1-609-495-2200 Revenue 4.49M
Industry Pharmaceuticals: Major Net Income -29,736,113.00
Sector Health Technology Employees 30
Fiscal Year-end 06 / 2025
View SEC Filings

PTN Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 6.383
Price to Book Ratio N/A
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA -0.667
Enterprise Value to Sales 4.392
Total Debt to Enterprise Value 0.03

PTN Efficiency

Revenue/Employee 149,669.667
Income Per Employee -991,203.767
Receivables Turnover N/A
Total Asset Turnover 0.313

PTN Liquidity

Current Ratio 1.012
Quick Ratio 1.012
Cash Ratio 0.987

PTN Profitability

Gross Margin 82.506
Operating Margin -674.329
Pretax Margin -662.261
Net Margin -662.261
Return on Assets -207.352
Return on Equity -263,431.192
Return on Total Capital -6,210.018
Return on Invested Capital -7,657.089

PTN Capital Structure

Total Debt to Total Equity N/A
Total Debt to Total Capital 123.285
Total Debt to Total Assets 5.495
Long-Term Debt to Equity N/A
Long-Term Debt to Total Capital 34.204
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Palatin Tech - PTN

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
(188.60K) 1.47M 4.85M 4.49M
Sales Growth
-259.84% +878.62% +230.53% -7.49%
Cost of Goods Sold (COGS) incl D&A
529.80K 703.54K 1.08M 785.49K
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
381.96K 486.02K 659.67K 687.86K
Depreciation
381.96K 486.02K 659.67K 687.86K
Amortization of Intangibles
- - - -
-
COGS Growth
- +32.79% +53.24% -27.14%
Gross Income
(718.40K) 764.91K 3.78M 3.70M
Gross Income Growth
- +206.47% +393.59% -1.88%
Gross Profit Margin
+380.92% +52.09% +77.79% +82.51%
2021 2022 2023 2024 5-year trend
SG&A Expense
29.88M 37.35M 37.26M 33.98M
Research & Development
12.93M 21.33M 22.63M 22.40M
Other SG&A
16.95M 16.03M 14.63M 11.58M
SGA Growth
+27.91% +25.00% -0.25% -8.80%
Other Operating Expense
- - - -
-
Unusual Expense
- 2.78M (1.03M) 7.66M
EBIT after Unusual Expense
(33.38M) (36.59M) (32.46M) (37.94M)
Non Operating Income/Expense
(212.40K) 419.83K 262.01K 8.22M
Non-Operating Interest Income
23.57K 29.96K 691.98K 376.84K
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- 29.68K 20.01K 17.11K
Interest Expense Growth
- -100.00% -32.58% -14.49%
Gross Interest Expense
- 29.68K 20.01K 17.11K
Interest Capitalized
- - - -
-
Pretax Income
(33.60M) (36.20M) (32.22M) (29.74M)
Pretax Income Growth
-49.81% -7.74% +11.00% +7.70%
Pretax Margin
+17,813.91% -2,465.06% -663.76% -662.26%
Income Tax
- - - (4.67M)
-
Income Tax - Current - Domestic
- - - -
-
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
- - - -
-
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(33.60M) (36.20M) (27.54M) (29.74M)
Minority Interest Expense
- - - -
-
Net Income
(33.60M) (36.20M) (27.54M) (29.74M)
Net Income Growth
-49.81% -7.74% +23.91% -7.97%
Net Margin Growth
+17,813.91% -2,465.06% -567.44% -662.26%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(33.60M) (36.20M) (27.54M) (29.74M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(33.60M) (36.20M) (27.54M) (29.74M)
EPS (Basic)
-3.5492 -3.793 -2.5291 -2.0233
EPS (Basic) Growth
-48.56% -6.87% +33.32% +20.00%
Basic Shares Outstanding
9.47M 9.54M 10.89M 14.70M
EPS (Diluted)
-3.5492 -3.793 -2.5291 -2.0233
EPS (Diluted) Growth
-48.56% -6.87% +33.32% +20.00%
Diluted Shares Outstanding
9.47M 9.54M 10.89M 14.70M
EBITDA
(30.22M) (36.10M) (32.83M) (29.59M)
EBITDA Growth
-30.00% -19.47% +9.07% +9.86%
EBITDA Margin
+16,022.50% -2,458.53% -676.32% -659.01%

Snapshot

Average Recommendation BUY Average Target Price 11.50
Number of Ratings 1 Current Quarters Estimate -0.42
FY Report Date 12 / 2024 Current Year's Estimate -1.66
Last Quarter’s Earnings -0.39 Median PE on CY Estimate N/A
Year Ago Earnings -2.02 Next Fiscal Year Estimate N/A
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 1 1 1 N/A
Mean Estimate -0.42 -0.46 -1.66 N/A
High Estimates -0.42 -0.46 -1.66 N/A
Low Estimate -0.42 -0.46 -1.66 N/A
Coefficient of Variance N/A N/A N/A N/A

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 1 1 2
OVERWEIGHT 0 0 0
HOLD 0 0 0
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Insider Actions for Palatin Tech - PTN

Date Name Shares Transaction Value
Jul 17, 2024 John K. A. Prendergast Director 83,280 Deposit into or withdrawal from voting trust 0.00
Jul 17, 2024 Anthony M. Manning Director 54,280 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 17, 2024 Anthony M. Manning Director 36,080 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 17, 2024 Arlene M. Morris Director 57,180 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 17, 2024 Arlene M. Morris Director 41,580 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 17, 2024 Alan W. Dunton Director 57,780 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 17, 2024 Alan W. Dunton Director 42,294 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 17, 2024 Joseph Stanley Hull Director 57,780 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 17, 2024 Joseph Stanley Hull Director 42,272 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 17, 2024 Robert K. deVeer Director 57,780 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 17, 2024 Robert K. deVeer Director 38,065 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 17, 2024 John K. A. Prendergast Director 63,310 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 8, 2024 Robert K. deVeer Director 34,845 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $2.03 per share 70,735.35
Mar 8, 2024 Robert K. deVeer Director 35,000 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $2.02 per share 70,700.00
Mar 8, 2024 Robert K. deVeer Director 35,460 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $2.01 per share 71,274.60
Mar 8, 2024 Robert K. deVeer Director 35,566 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $2.01 per share 71,487.66
Mar 8, 2024 Robert K. deVeer Director 37,574 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $2 per share 75,148.00

Palatin Tech in the News